Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The bulk of those shipments were from Eli Lilly, which manufactures active ingredients for its popular obesity drug Zepbound in Ireland.
- Simplified Text
-
The bulk of weight-loss drug ingredient shipments from Ireland were from Eli Lilly
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "company": "Eli Lilly", "product": "Active ingredients for Zepbound", "location": "Ireland", "shipments": "Bulk of weight-loss drug ingredient shipments" } - Subject Tags
- UUID
- 9fdae134-8a5b-4bdd-bc18-ca24e9ddf35b
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 8:58 PM (3 days ago)
- Last Updated
- September 11, 2025 at 8:58 PM (3 days ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
53
claims
🔥
3 days ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html
US drugmakers using Ireland for tax advantages face billions in tariffs on European medicines. Shifting production to the US increases costs. The situation highlights tax strategies and their impact.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.